Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.

Quick Stats
Studies 225
Trials 100
Formula C78H111N21O19
Clear All
Utility 3
pubmed 2008

Evidence of a possible role for Lys-gamma3-MSH in the regulation of adipocyte function.

Harmer. Stephen C SC; Pepper. David J DJ; Cooke. Katy K; Bennett. Hugh P J HP; Bicknell. Andrew B AB

The paper shows that Lys‑γ3‑MSH (melanotan‑I) can trigger fat‑cell breakdown in a lab model by activating the enzymes that release stored fat, suggesting it might help with fat loss, but the work is only in mouse cells and we don’t yet know how it works in people or what dose is safe.

Utility 3
pubmed Jan 18, 2006

Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

Hadley. Mac E ME; Dorr. Robert T RT

Melanotan‑I is a synthetic peptide that can give a deep tan without UV exposure, which might lower skin‑cancer risk. Melanotan‑II (also called PT‑141) was originally studied for erectile dysfunction and now shows promise for improving sexual function in both men and women. Both peptides have been tested in early‑phase human trials, but they are not yet approved for general use.

Utility 3
pubmed 2000

Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I.

Bhardwaj. R R; Hadley. M E ME; Dorr. R T RT; Dvorakova. K K; Brooks. C C; Blanchard. J J

This study shows that a tiny implant made of a slow‑release polymer can steadily release the tanning peptide Melanotan‑I for about three months, keeping the skin darker and boosting the protective black pigment (eumelanin). The implant worked in lab tests and in guinea pigs, suggesting a way to get long‑lasting tanning without daily shots, but it’s still an invasive method and hasn’t been proven safe in people yet.

Utility 3
pubmed Nov 15, 2005

Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles.

Fitzgerald. Liesel M LM; Fryer. Jayne L JL; Dwyer. Terence T; Humphrey. Stuart M SM

The study shows that melanotan (a synthetic peptide) boosts skin melanin levels in people, and it works even better in those with certain MC1R gene variants that usually give lighter skin and higher sun sensitivity. This means melanotan could help people with these variants get more natural UV protection through increased skin pigment.

Utility 3
pubmed Oct 10, 2007

Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways.

Newton. Richard A RA; Roberts. Donald W DW; Leonard. J Helen JH; Sturm. Richard A RA

The study shows that people with red‑hair/fair‑skin genetic variants (MC1R RHC alleles) have a blunted response to melanocortin peptides like melanotan‑I. Their skin cells don’t boost the usual pigmentation signals (cAMP, MITF, SLC45A2) or activate related pathways (c‑Fos, p38) as well, which helps explain why they tan poorly and may get less benefit from melanotan‑I.

Utility 3
pubmed Apr 5, 2009

Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268.

Giuliani. Daniela D; Ottani. Alessandra A; Minutoli. Letteria L; Stefano. Vincenzo Di VD; Galantucci...

In a gerbil stroke model, giving the melanocortin peptide NDP‑α‑MSH (the same molecule sold as melanotan‑I) a few hours after a brain attack reduced damage and helped the animals learn and remember better for weeks. The benefit depended on activating the MC4 receptor and was linked to higher levels of a brain‑repair gene called Zif268.

Utility 3
pubmed Apr 1, 1997

Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).

Van Bergen. P P; Kleijne. J A JA; De Wildt. D J DJ; Versteeg. D H DH

In rats, the peptide melanotan‑I (NDP‑MSH) didn’t change blood pressure or heart rate even at very high doses, while a related peptide (gamma‑2‑MSH) raised both, and ACTH‑(1‑24) lowered blood pressure, raised heart rate, and blocked the pressor effect of gamma‑2‑MSH. This suggests melanotan‑I is unlikely to cause immediate cardiovascular spikes, but the findings are from animals and may not fully translate to humans.

Utility 3
pubmed Mar 31, 2006

Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons.

Newman. Erika A EA; Chai. Bioa-Xin BX; Zhang. Weizhen W; Li. Ji-Yao JY; Ammori. John B JB; Mulhollan...

The study shows that activating the melanocortin‑4 receptor (the target of melanotan‑I) in hypothalamic brain cells causes a rise in internal calcium via a specific G‑protein (Gαq) and phospholipase‑C pathway, and this effect can be blocked by known antagonists. While the work is done in cultured mouse neurons and not in people, it confirms that melanotan‑I can trigger intracellular signaling that may influence appetite and metabolism.

Utility 3
pubmed 2004

Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.

Hoggard. N N; Rayner. D V DV; Johnston. S L SL; Speakman. J R JR

A mouse study found that giving the peptide melanotan‑I (a modified alpha‑MSH) by injection under the skin raised the animals' resting metabolism, even in mice that lack leptin, while a related protein (AgRP) did not lower metabolism. This suggests the peptide can boost energy burn independent of leptin signals, but the work is only in rodents and uses injections, so it’s not ready for direct human use.

Utility 3
pubmed Jan 1, 2013

[Nle3,d-Phe6 ]-γ2 -melanocyte-stimulating hormone possesses the renal excretory but not the cardiovascular actions of the native γ2 -melanocyte-stimulating hormone in anaesthetized rats.

Cope. Georgina G; Flanagan. Evelyn T ET; Houghton. Belinda L BL; Walsh. Sarah A SA; Johns. Edward J...

In rats, the synthetic peptide melanotan‑I (NDP‑γ2‑MSH) makes the kidneys dump a lot more salt and water, especially when the animal eats a high‑salt diet, but it does not raise blood pressure like the natural hormone does. This kidney effect works even if the kidney nerves are cut and seems to involve MC3 receptors in kidney cells.

Utility 3
pubmed Jan 13, 2005

Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors.

Sánchez-Más. Jesús J; Guillo. Lidia A LA; Zanna. Paola P; Jiménez-Cervantes. Cel...

The study shows that the skin‑color receptor (MC1R) becomes less responsive when repeatedly stimulated, and this “turn‑off” is driven by two proteins called GRK2 and GRK6. Blocking GRK2 makes the receptor react more strongly, while GRK6 also lowers the receptor’s baseline activity. These mechanisms could explain why the tanning effects of melanotan‑I may fade with frequent use.

Utility 3
pubmed Oct 30, 2003

Agouti-related protein antagonizes glucocorticoid production induced through melanocortin 4 receptor activation in bovine adrenal cells: a possible autocrine control.

Doghman. Mabrouka M; Delagrange. Philippe P; Blondet. Antonine A; Berthelon. Marie-Claude MC; Durand...

The study shows that a synthetic version of the hormone alpha‑MSH (similar to melanotan‑I) can boost cortisol production in adrenal cells by activating the MC4‑receptor, and that the naturally occurring protein AGRP can block this effect. This suggests that using melanotan‑I might raise stress‑hormone levels, which could impact metabolism and performance, and that blocking MC4‑R could counteract that.

Utility 3
pubmed Nov 9, 2001

Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor.

Jiménez-Cervantes. C C; Germer. S S; González. P P; Sánchez. J J; Sánchez. C O C...

The study found two common genetic variants of the skin‑color receptor MC1R (Ile40Thr and Val122Met) that don’t respond as well to melanocortin signals, meaning people with these variants tan less and may have higher skin‑cancer risk. This matters for anyone using melanotan‑I, a peptide that works by activating MC1R, because the drug may be less effective for them.

Utility 3
pubmed Jan 25, 2016

The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.

Brennan. Rebekah R; Wells. John S G JSG; Van Hout. Marie Claire MC

This systematic review looks at how people inject a range of image‑ and performance‑enhancing drugs, including the peptide melanotan‑I. It shows why users start (appearance, youth, health goals), where they get the products (often online), and what health risks and community behaviours are linked to this practice.

Utility 3
pubmed Jun 21, 2001

Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.

Haskell-Luevano. C C; Holder. J R JR; Monck. E K EK; Bauzo. R M RM

Researchers broke down a larger peptide (NDP‑MSH) into smaller pieces and found that a four‑amino‑acid fragment can strongly activate the brain MC4 receptor, which helps control hunger and energy use. A three‑amino‑acid piece also works but is much weaker. The study shows which ends of the original peptide matter for activity, giving clues for designing simpler, potentially more stable compounds.

Utility 3
pubmed Apr 17, 1998

Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor.

Frändberg. P A PA; Doufexis. M M; Kapas. S S; Chhájlani. V V

A single genetic change (Arg151Cys) in the skin’s pigment receptor (MC1R) makes it bind the hormone but unable to signal, causing red hair, very fair skin, and poor tanning. This means that people with this mutation won’t respond to melanotan‑I or similar tanning peptides.

Utility 3
pubmed Sep 1, 1997

Melanotropic peptides-lipid bilayer interaction. Comparison of the hormone alpha-MSH to a biologically more potent analog.

Biaggi. M H MH; Riske. K A KA; Lamy-Freund. M T MT

The study shows that the synthetic peptide melanotan‑I (a more potent version of the natural hormone alpha‑MSH) sticks to cell‑like membranes much more strongly than the natural hormone and can slip deeper into the membrane, which may explain why it works better and lasts longer.

Utility 3
pubmed Jan 3, 2023

Effects of the central melanocortin system on feed intake, metabolic hormones and insulin action in the sheep.

Ehrhardt. Richard A RA; Giesy. Sarah L SL; Hileman. Stanley M SM; Houseknecht. Karen L KL; Boisclair...

In sheep, giving the peptide melanotan‑I directly into the brain cuts food intake, raises thyroid hormones (T3 and T4), and lowers leptin at higher feeding levels, but it also makes the liver less responsive to insulin's signal to stop making glucose. It doesn't change blood sugar, insulin, or cortisol levels.

Utility 3
pubmed Jan 9, 1997

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.

Fan. W W; Boston. B A BA; Kesterson. R A RA; Hruby. V J VJ; Cone. R D RD

The study shows that a brain‑acting version of the melanotan‑II peptide can sharply cut food intake in mice, while blocking the same pathway makes them eat more. This supports the idea that the brain’s melanocortin system normally keeps hunger in check, and that interfering with it (as the agouti gene does) leads to obesity.

Utility 3
pubmed Mar 7, 2017

Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.

Habbema. Louis L; Halk. Anne Berthe AB; Neumann. Martino M; Bergman. Wilma W

The review warns that buying and using unregulated melanotan I or II (synthetic alpha‑MSH peptides) can be dangerous. Because the products aren’t tested, you don’t know the exact dose or how they’re made, and they have been linked to skin problems, including changes in moles and a few reported melanomas. The only approved alpha‑MSH drug, afamelanotide, has been studied and is considered safe for specific medical uses.